What happened
HLB Therapeutics updated the terms of convertible bonds to raise US$3.6M, about 1.9% of its market value.
For context, this raise equals about 1.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$3.6M |
| vs. market value | 1.9% |
| Filed | 2026-08-21, [Amended] Material event report (convertible bonds) |
| Source | DART rcept 20260821000006 → open original filing |
Source: DART. Information only, not investment advice.